New tools are being integrated into the research process to ease patients’ access to clinical trials and improve their experience.
by Bradley Jones
Medical oncologist Leisha A. Emens discusses the significance of the first U.S. Food and Drug Administration approval of an immunotherapy treatment for breast cancer.
Patients diagnosed with low-risk prostate cancer are increasingly opting against immediate surgery or radiation in favor of regularly monitoring their disease.
A new survey suggests that young adults with colorectal cancer struggle to receive an accurate, prompt diagnosis.
A study investigates how people who have been diagnosed with cancer feel about being called survivors.
A recent study evaluated whether hyperglycemia is associated with prostate cancer incidence and mortality.
The U.S. Food and Drug Administration has for the first time approved an immunotherapeutic for breast cancer.
What are the side effects of immune checkpoint inhibitors and how do they arise?
Bob Riter: The Bridge Builder
donate to the AACR
The AACR Cancer Progress Report 2018, which is published annually by the American Association for Cancer Research, tracks recent developments that impact cancer care. Click “Progress Report” below to find out more.